Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Apogee Therapeutics
Apogee Therapeutics to Host Inaugural Virtual R&D Day on December 2, 2024
November 18, 2024
From
Apogee Therapeutics
Via
GlobeNewswire
Tickers
APGE
Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2024 Financial Results
November 12, 2024
From
Apogee Therapeutics
Via
GlobeNewswire
Tickers
APGE
Apogee Therapeutics to Participate in Upcoming November Investor Conferences
November 04, 2024
From
Apogee Therapeutics
Via
GlobeNewswire
Tickers
APGE
Apogee Therapeutics Announces Results Up to 9 Months from Phase 1 Trial of APG777, its Novel Half-Life Extended Anti-IL-13 Antibody for the Treatment for Atopic Dermatitis and Other Inflammatory Diseases
October 24, 2024
From
Apogee Therapeutics
Via
GlobeNewswire
Tickers
APGE
Apogee Therapeutics Announces Poster Presentation at the ACAAI 2024 Annual Scientific Meeting
October 16, 2024
From
Apogee Therapeutics
Via
GlobeNewswire
Tickers
APGE
Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit
September 12, 2024
From
Apogee Therapeutics
Via
GlobeNewswire
Tickers
APGE
Apogee Therapeutics Appoints Jeff S. Hartness as Chief Commercial Officer
September 09, 2024
From
Apogee Therapeutics
Via
GlobeNewswire
Tickers
APGE
Apogee Therapeutics Strengthens Team with Appointments of Industry Leaders to Board of Directors and Management
June 22, 2023
From
Apogee Therapeutics
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.